{"id":"NCT01512108","sponsor":"Novo Nordisk A/S","briefTitle":"Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone","officialTitle":"A 52-week, Multi-centre, Open-labelled, Randomised (2:1), Parallel-group Trial With an Active Control (Two OADs Combination Therapy) to Evaluate the Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Monotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-01-10","primaryCompletion":"2013-04-26","completion":"2013-04-26","firstPosted":"2012-01-19","resultsPosted":"2014-05-28","lastUpdate":"2017-12-18"},"enrollment":363,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"liraglutide","otherNames":[]},{"type":"DRUG","name":"oral anti-diabetic drug","otherNames":[]}],"arms":[{"label":"Liraglutide + an OAD therapy","type":"EXPERIMENTAL"},{"label":"Two OADs combination therapy","type":"ACTIVE_COMPARATOR"}],"summary":"This trial was conducted in Japan. The aim of this trial was to evaluate the safety and efficacy of once daily administration of liraglutide in combination with an oral anti-diabetic drug (OAD) in Japanese subjects with type 2 diabetes who are insufficiently controlled on OAD monotherapy. All subjects will continue their pre-trial OAD (either glinide, metformin, alpha-glucosidase inhibitor or thiazolidinedione) during the trial at unchanged type and dose.","primaryOutcome":{"measure":"Incidence of Treatment Emergent Adverse Events (AEs)","timeFrame":"Week 0 to Week 52 + 7 days","effectByArm":[{"arm":"Liraglutide 0.9 mg/Day","deltaMin":361,"sd":null},{"arm":"Additional OAD","deltaMin":331,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":8},"locations":{"siteCount":36,"countries":["Japan"]},"refs":{"pmids":["26816604","28984041"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":240},"commonTop":["Nasopharyngitis","Constipation","Diabetic retinopathy","Nausea","Diarrhoea"]}}